TriSalus Life Sciences, Inc. (TLSIW) Gross margin 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) gross margin by fiscal year — reported gross profit divided by reported revenue.
84.6%FY2025 · since FY2022: 81.8% → 84.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 84.6% | -1.5 pp |
| FY2024 | 86.1% | +0.1 pp |
| FY2023 | 85.9% | +4.1 pp |
| FY2022 | 81.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net incomeTLSIW Net marginTLSIW Gross profitTLSIW Operating incomeTLSIW Operating marginTLSIW Operating cash flowTLSIW Free cash flowTLSIW Capital expendituresTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Total liabilitiesTLSIW Shareholders’ equityTLSIW overview →